Company: DERM
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041214
Chunk: 12

Company: Journey Medical Corp
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 12
---
 in the “Investors” section of our website at www.journeymedicalcorp.com and on the website of the SEC at www.sec.gov. You may obtain, free of charge, a copy of our Annual Report on Form 10-K for the year ended December 31, 2024, including financial statements, by writing to our Corporate Secretary, Ramsey Alloush, or by email at info@jmcderm.com. Upon request, we will also furnish any exhibits to the Annual Report on Form 10-K for the year ended December 31, 2024 as filed with the SEC. Q: How does the Board recommend that I vote my shares? A: As to the proposals to be voted on at the Annual Meeting, our Boards unanimously recommends that you vote: • “ FOR ” the election to the Board of each of the six nominees named in Proposal No. 1; • “ FOR ” Proposal No. 2, the ratification of the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025; and • “ FOR ” Proposal No. 3, the approval of the Fourth Amended and Restated Certificate of Incorporation providing for, among other things, officer exculpation. 5

TABLE OF CONTENTS

CORPORATE GOVERNANCE Our Board of Directors Our Bylaws provide that our Board shall consist of between one to nine directors, and such number of directors within this range may be determined from time to time by resolution of our Board or our stockholders. In 2024, our Board set the number of directors at six. The following individuals are being nominated to serve on our Board (See “ Proposal 1 — Election of Directors; Nominees ”):

| Name                       | ​ | ​ | Age | ​ | ​ | Position                                      | ​ | ​ | DirectorSince | ​ |
| Lindsay A. Rosenwald, M.D. | ​ | ​ |  70 | ​ | ​ | Executive Chairman of the Board of Directors  | ​ | ​ |          2014 | ​ |
| Claude Maraoui             | ​ | ​ |  59 | ​ | ​ | President, Chief Executive Officer & Director | ​ | ​ |          2016 | ​ |
| Neil Herskowitz            | ​ | ​ |  68 | ​ | ​ | Director                                      | ​ | ​ |          2021 | ​ |
| Justin Smith               | ​ | ​